Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
3+ day, 3+ hour ago (572+ words) NEW YORK, Sept. 10, 2026 Sections 11 and 15 of the Securities Act impose liability for registration statements containing untrue statements of material fact. A securities class action alleges Aardvark Therapeutics' IPO paperwork described ARD-101 as "99% restricted to the gut" with "no serious adverse…...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
3+ day, 9+ hour ago (147+ words) Sep 10, 2026, 10:00 ET The class action concerns whether Capricor and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until September 28, 2026, to ask the Court to appoint you as Lead Plaintiff…...
Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
4+ day, 5+ hour ago (518+ words) NEW YORK, Sept. 9, 2026 Institutional investors with REGN positions may need to assess alleged clinical-trial disclosure failures that preceded a $102.09 per-share decline from the Class Period high. This notice focuses on fiduciary review, portfolio loss documentation, and lead plaintiff considerations. REGN…...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
4+ day, 2+ hour ago (330+ words) Sep 09, 2026, 17:02 ET Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now. FDA Extends BLA Review Following Post-AdCom Submissions On Aug. 24, Capricor announced that the FDA has extended the Prescription Drug…...
HDB INVESTOR DEADLINE: HDFC Bank Limited Investors with Substantial Losses Have Opportunity to Lead the HDFC Shareholder Class Action Lawsuit Before October 13, 2023
4+ day, 2+ hour ago (311+ words) Sep 09, 2026, 17:07 ET SAN FRANCISCO, Sept. 9, 2026 /PRNewswire/ -- Hagens Berman, a national law firm noted for its preeminent work in securities class action litigation, notifies investors in HDFC Bank Limited (NYSE: HDB) of a pending securities fraud class action. HDFC Bank Limited…...
BABA INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
5+ day, 41+ min ago (115+ words) San Francisco, California--(Newsfile Corp. - September 8, 2026) - Hagens Berman Sobol Shapiro LLP urges Alibaba Group Holding Limited (NYSE:......
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline
5+ day, 54+ min ago (39+ words) San Francisco, California--(Newsfile Corp. - September 8, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with......
MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law
5+ day, 11+ hour ago (175+ words) Published on 09/08/2026 at 08:09 am EDT If you suffered substantial losses and wish to serve as lead plaintiff of the Regeneronclass action lawsuit, please provide your information here: You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller…...
CAPR Lawsuit Alert: Capricor Therapeutics Investors Face September 28 Deadline After 64% Stock Drop Tied to Clinical Data Disclosure
5+ day, 13+ hour ago (279+ words) Sep 08, 2026, 06:06 ET Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Deramiocel and the integrity of the clinical data supporting its Biologics License Application leading to a 64% stock drop. NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Leading securities law…...
1 WEEK REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline
6+ day, 1+ hour ago (20+ words) San Diego, California--(Newsfile Corp. - September 7, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers......